According to AlphaMoat, in the latest data month Mendra (mendra.com) received 0 monthly visits — ranked #0 of 17,407 AI websites with traffic data, and #0 of 3,173 in Industry Services.
What is Mendra
Mendra is an AI-native rare-disease biopharma that uses AI to accelerate clinical development and commercialization of breakthrough therapies for high-unmet-need areas, aiming to bring innovative drugs to severely underserved rare and ultra-rare disease patients.
- 01RarePath creates paths for scientists so rare-disease therapy development need not keep depending on large-pharma acquisitions
- 02it partners with academic researchers, biotech companies, and patient foundations to jointly fund, license, and commercialize therapies
- 03focused on high unmet need in rare disease, it covers the full chain from in-licensing to clinical development to commercialization
It conducts partnerships and business development with academia, biotech companies, and patient foundations; the website does not publish a standardized price list and requires discussing collaboration; the page lists no explicit product price figures.
Popular in Industry Services
Data month: — · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.